The proposed technology makes use of artificial intelligence, analytics on-chip and cloud-based services to monitor and predict reliability of the chip throughout its life, which is also of use at the system and service level. The company argues that as designs go ever smaller in dimensions, quality and reliability become harder and more expensive to achieve. It is proposing to monitor IC behaviour in-use to determine if a failure is becoming likely. An orderly chip or board swap can be a lot less expensive than recovery from a failure in service, ProteanTec's argues.
ProteanTec says its universal chip telemetry provides inferred measurements of chip health and performance monitoring.
Investors include Avigdor Willenz, Intel Capital, ITI Venture Capital Partners, Mitsubishi UFJ Capital, Redline Capital Management S.A., Viola Ventures, WRVI Capital, Zeev Ventures and others.
The latest funding round brings the amount raised by ProteanTecs to more than $50 million, not surprising when it is considered that the founding team comes largely from Mellanox Technologies (see Nvidia to buy Mellanox for $6.9 billion ).
"We offer a one-stop cloud-based platform, that combines data derived from proprietary agents embedded in chips, with machine learning and data analytics," said Shai Cohen, proteanTecs' co-founder and CEO, in a statement. "This significantly improves chip and system production quality, while tracking operational reliability and alerting on faults before they become failures. ProteanTecs provides unprecedented insights throughout the value chain, from chip vendors to system vendors and digital service providers."
Related links and articles: